Free Webinar · July 17 12pm PT · Reserve your spot →
PTSD that hasn’t responded sufficiently to two trauma-focused therapy modalities and pharmacotherapy is generally considered treatment-resistant. The non-response rate to first-line treatment is roughly 40% [1] and partial response is even more common. Standard escalation now includes ketamine-assisted therapy, MDMA-assisted therapy in approved settings, and TMS. Functional medicine adds a parallel investigation: what biology has trauma left in this body, and what can be addressed?
Trauma is a whole-body event. Chronic, repeated, or developmental trauma alters the HPA axis, the autonomic nervous system, the gut microbiome, the immune system, and gene expression itself [2]. Cognitive and somatic therapies work on real systems — but they don’t repair the inflammatory load, the gut barrier, the nutrient depletion, or the mitochondrial dysfunction that decades of nervous system activation can create.
When the biology stays activated, the body keeps signaling threat — and the brain keeps interpreting those signals as PTSD symptoms.
The systems most consistently dysregulated in chronic and complex PTSD:
PTSD often shows a paradoxical pattern — low cortisol output despite high stress reactivity. DUTCH testing maps the daily cortisol pattern, DHEA production, and the metabolites that reveal whether your stress system is in over- or under-activation [3].
Chronic activation reduces parasympathetic capacity, which downstream affects digestion, immunity, and mood regulation.
Trauma-exposed populations consistently show distinct microbiome signatures — reduced SCFA producers, increased pro-inflammatory species. The gut-brain axis becomes part of the symptom picture.
Elevated CRP, IL-6, and TNF-α are common in PTSD and contribute directly to mood, cognition, and sleep symptoms.
Sustained stress depletes the cellular energy systems. Fatigue, cognitive symptoms, and exercise intolerance often track this.
Cortisol patterns, melatonin production, and REM disruption are all measurable and addressable.
Magnesium, B vitamins, vitamin D, omega-3 EPA, and zinc are often profoundly depleted in chronic stress states.
Chronic stress shifts pregnenolone away from sex hormone production toward cortisol — the "pregnenolone steal" pattern. Low DHEA, low testosterone, and disrupted estrogen-progesterone balance follow.
Some research suggests altered endocannabinoid signaling in PTSD, with implications for treatment.
DUTCH Plus is often the highest-yield single test for PTSD biology — it maps the cortisol pattern, the DHEA production, the metabolite ratios, and the sex hormones in one analysis. The GI Effects panel reveals microbiome shifts and gut inflammation. KBMO FIT 176 with Gut Barrier Panel reveals food sensitivities and the intestinal permeability that chronic PTSD states often produce. Blood markers for inflammation, thyroid, and nutrient status come from our standard bundle. NutrEval shows mitochondrial function via organic acids.
If you’ve done DUTCH or HRV-based testing elsewhere, integrate it.
Phase one usually focuses on the HPA axis, gut barrier, and acute nutrient repletion — these tend to be the foundational pieces in chronic PTSD. Mineral repletion, vagal tone interventions, sleep architecture support, and adaptogenic protocols come together with whatever therapy you’re already doing. Phase two often addresses sex hormones, mitochondrial recovery, and longer-term inflammation.
For patients pursuing legal psychedelic-assisted therapy (ketamine, eventually psilocybin in approved settings), we offer pre-treatment optimization and integration support — one of the strongest emerging applications of functional medicine for trauma recovery. The biological foundation matters: it shapes both the experience and the durability of the outcome.
You’re not stopping therapy. You’re giving your body the biological foundation that lets the therapy actually land.
Program structure: main services page
This is for people whose trauma-focused therapy has been valuable but incomplete, who suspect their body is still carrying the load, and who are ready to invest in addressing the biological dimension of trauma recovery. We work alongside therapists and prescribers — coordinated, parallel care.